Trials / Conditions / Childhood Absence Epilepsy

Childhood Absence Epilepsy

11 registered clinical trials studyying Childhood Absence Epilepsy — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Abs NCT06315322	UCB Biopharma SRL	Phase 3
Completed	Assessing Comorbidities in Epilepsy Using Eye Movement Recordings NCT06310772	Eysz, Inc.	—
Completed	A Study to Test the Long-term Safety, Tolerability and Efficacy of Brivaracetam in Study Participants 2 to 26 NCT05109234	UCB Biopharma SRL	Phase 3
Active Not Recruiting	A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 NCT04666610	UCB Biopharma SRL	Phase 3
Terminated	Flunarizine for Treatment Resistant Absence Epilepsy NCT06153186	University of British Columbia	Phase 2
Terminated	Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Tr NCT03355300	Radius Pharmaceuticals, Inc.	Phase 2
Terminated	Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures NCT03336242	Radius Pharmaceuticals, Inc.	Phase 2
Completed	A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence Epi NCT00361010	The Cleveland Clinic	N/A
Completed	Why Are Patients With Absence Seizures Absent? A Brain Imaging Study NCT00393666	Yale University	—
Completed	Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study NCT00088452	Children's Hospital Medical Center, Cincinnati	Phase 3
Completed	Search for Genes Influencing Childhood Absence Epilepsy (CAE) Study NCT00041951	Icahn School of Medicine at Mount Sinai	—